Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-06 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.500 | -0.620 | -0.1200 | ||||
REV | 2.700M | 5.698M | 2.998M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
SYRS | Syros Pharmaceuticals | 7.94 | -0.02 | -0.25% | 489.4M |
You can purchase shares of Syros Pharmaceuticals (NASDAQ: SYRS) through any online brokerage.
Other companies in Syros Pharmaceuticals’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Jounce Therapeutics (NASDAQ:JNCE) and Inozyme Pharma (NASDAQ:INZY).
The latest price target for Syros Pharmaceuticals (NASDAQ: SYRS) was reported by HC Wainwright & Co. on 2020-11-04. The analyst firm set a price target for 15.00 expecting SYRS to rise to within 12 months (a possible 88.92% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Syros Pharmaceuticals (NASDAQ: SYRS) is $7.94 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Syros Pharmaceuticals.
There is no upcoming split for Syros Pharmaceuticals.